Diagnostic Medical Systems Stock

Equities

ALDMS

FR0012202497

Advanced Medical Equipment & Technology

Market Closed - Euronext Paris 09:15:46 2024-04-25 am EDT 5-day change 1st Jan Change
1.04 EUR -0.48% Intraday chart for Diagnostic Medical Systems -7.96% -8.37%
Sales 2021 39.99M 42.92M Sales 2022 37.06M 39.78M Capitalization 16.28M 17.48M
Net income 2021 -3M -3.22M Net income 2022 -6M -6.44M EV / Sales 2021 0.78 x
Net Debt 2021 11.67M 12.53M Net Debt 2022 10.98M 11.78M EV / Sales 2022 0.74 x
P/E ratio 2021
-5.08 x
P/E ratio 2022
-2.39 x
Employees 120
Yield 2021 *
-
Yield 2022
-
Free-Float 91.86%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.48%
1 week-7.96%
Current month-8.37%
1 month-9.96%
3 months-11.86%
6 months+12.31%
Current year-8.37%
More quotes
1 week
0.99
Extreme 0.99
1.10
1 month
0.99
Extreme 0.99
1.15
Current year
0.99
Extreme 0.99
1.37
1 year
0.79
Extreme 0.794
1.60
3 years
0.79
Extreme 0.794
1.83
5 years
0.79
Extreme 0.794
2.51
10 years
0.63
Extreme 0.63
3.30
More quotes
Managers TitleAgeSince
Chairman - 11-09-26
Director/Board Member - -
Investor Relations Contact - -
Members of the board TitleAgeSince
Chairman - 11-09-26
Director/Board Member - -
Director/Board Member - -
More insiders
Date Price Change Volume
24-04-25 1.04 -0.48% 2 032
24-04-24 1.045 +0.97% 3,966
24-04-23 1.035 +2.48% 5,602
24-04-22 1.01 +1.61% 5,308
24-04-19 0.994 -12.04% 56,981

Real-time Euronext Paris, April 25, 2024 at 09:15 am EDT

More quotes
Diagnostic Medical Systems (DMS) is France's leader in the development, design, and production of imaging systems for digital and conventional radiology and osteodensitometry. The group's activity is organized around two sectors: - radiology equipment and osteodensitometers sales: mobile radiology units, floating table tops, operating room mobile amplifiers, ultrasound osteodensitometers (designed to chart the bone micro-architecture) and X ray osteodensitometers (designed to measure bone density), etc. The group also proposes devices distribution and maintenance activities; - development of biotechnology solutions: in the fields of arthrosis treatment and regenerative medicine. Products and services are marketed primarily by exclusive retailers. Net sales (not including sold divisions) are distributed geographically as follows: Europe (62.6%), North and South America (17.7%), Asia (6.8%), Middle East (4.5%), Africa (3.8%), Oceania (1.1%) and other (3.5%).
More about the company